Page last updated: 2024-11-05

thiotepa and MELAS Syndrome

thiotepa has been researched along with MELAS Syndrome in 1 studies

Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).

MELAS Syndrome: A mitochondrial disorder characterized by focal or generalized seizures, episodes of transient or persistent neurologic dysfunction resembling strokes, and ragged-red fibers on muscle biopsy. Affected individuals tend to be normal at birth through early childhood, then experience growth failure, episodic vomiting, and recurrent cerebral insults resulting in visual loss and hemiparesis. The cortical lesions tend to occur in the parietal and occipital lobes and are not associated with vascular occlusion. VASCULAR HEADACHE is frequently associated and the disorder tends to be familial. (From Joynt, Clinical Neurology, 1992, Ch56, p117)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BERTRAM, DS1

Other Studies

1 other study available for thiotepa and MELAS Syndrome

ArticleYear
OBSERVATIONS ON THE CHEMOSTERILANT EFFECT OF AN ALKYLATING AGENT, THIO-TEPA, ON WILD-CAUGHT ANOPHELES GAMBIAE VAR. MELAS (THEO.) IN GAMBIA, WEST AFRICA, AND ON LABORATORY-BRED A. G. GAMBIAE GILES AND AEDES AEGYPTI (L.).
    Transactions of the Royal Society of Tropical Medicine and Hygiene, 1963, Volume: 57

    Topics: Aedes; Africa, Western; Alkylating Agents; Animals; Anopheles; Chemosterilants; Gambia; MELAS Syndro

1963